{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:42Z","timestamp":1786119102317,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/fjc.0b013e318196736c","type":"journal-article","created":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T03:13:56Z","timestamp":1231902836000},"page":"77-85","source":"Crossref","is-referenced-by-count":14,"title":["Pranlukast Attenuates Ischemia-like Injury in Endothelial Cells Via Inhibiting Reactive Oxygen Species Production and Nuclear Factor-\u03baB Activation"],"prefix":"10.1097","volume":"53","author":[{"given":"San-Hua","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Mei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Tan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Bi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-Qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210208","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/med.20071","article-title":"Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends.","volume":"27","author":"Capra","year":"2007","journal-title":"Med Res Rev"},{"key":"R2-11-20210208","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03256645","article-title":"Recent advances in the management of asthma using leukotriene modifiers.","volume":"2","author":"Kemp","year":"2003","journal-title":"Am J Respir Med"},{"key":"R3-11-20210208","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/00003495-200363100-00005","article-title":"Pranlukast: a review of its use in the management of asthma.","volume":"63","author":"Keam","year":"2003","journal-title":"Drugs"},{"key":"R4-11-20210208","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuroscience.2006.02.051","article-title":"Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats.","volume":"140","author":"Fang","year":"2006","journal-title":"Neuroscience"},{"key":"R5-11-20210208","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2005.06.046","article-title":"Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice.","volume":"1053","author":"Yu","year":"2005","journal-title":"Brain Res"},{"key":"R6-11-20210208","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbrc.2006.09.057","article-title":"Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.","volume":"350","author":"Wang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R7-11-20210208","first-page":"871","article-title":"Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats.","volume":"23","author":"Zhang","year":"2002","journal-title":"Acta Pharmacol Sin"},{"key":"R8-11-20210208","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/02713680701487871","article-title":"The role of clusterin in in vitro ischemia of human retinal endothelial cells.","volume":"32","author":"Kim","year":"2007","journal-title":"Curr Eye Res"},{"key":"R9-11-20210208","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1161\/01.STR.31.7.1744","article-title":"Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells.","volume":"31","author":"Xu","year":"2000","journal-title":"Stroke"},{"key":"R10-11-20210208","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14728222.11.2.123","article-title":"NF-kappa B as a therapeutic target in neurodegenerative diseases.","volume":"11","author":"Camandola","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"R11-11-20210208","doi-asserted-by":"crossref","first-page":"C362","DOI":"10.1152\/ajpcell.00535.2005","article-title":"Low shear stress preferentially enhances IKK activity through selective sources of ROS for persistent activation of NF-kappaB in endothelial cells.","volume":"292","author":"Mohan","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"R12-11-20210208","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0006-291X(03)00496-0","article-title":"TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation.","volume":"303","author":"Chandrasekar","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-11-20210208","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1006\/jmcc.1997.0497","article-title":"Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion.","volume":"29","author":"Vanden Hoek","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"R14-11-20210208","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11010-006-9289-1","article-title":"Reduction in the in vitro expression of brain-pancreas relative protein by oxygen and glucose-deprivation.","volume":"295","author":"Lin","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"R15-11-20210208","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00004647-200003000-00017","article-title":"Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia.","volume":"20","author":"Stephenson","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"R16-11-20210208","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.STR.0000120732.45951.26","article-title":"Nuclear factor-kappaB contributes to infarction after permanent focal ischemia.","volume":"35","author":"Nurmi","year":"2004","journal-title":"Stroke"},{"key":"R17-11-20210208","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0304-3940(00)01245-3","article-title":"Nuclear factor-kappa B activation in permanent intraluminal focal cerebral ischemia in the rat.","volume":"288","author":"Seegers","year":"2000","journal-title":"Neurosci Lett"},{"key":"R18-11-20210208","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1046\/j.1365-2222.2003.01673.x","article-title":"Pranlukast inhibits NF-kappa B activation in human monocytes\/macrophages and T cells.","volume":"33","author":"Ichiyama","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"R19-11-20210208","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000081294","article-title":"Pranlukast inhibits NF-kappaB activation and MUC2 gene expression in cultured human epithelial cells.","volume":"73","author":"Ishinaga","year":"2005","journal-title":"Pharmacology"},{"key":"R20-11-20210208","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/jmcc.2001.1505","article-title":"Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy.","volume":"34","author":"Higuchi","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"R21-11-20210208","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jneuroim.2006.10.003","article-title":"SOD1 overexpression alters ROS production and reduces neurotoxic inflammatory signaling in microglial cells.","volume":"182","author":"Dimayuga","year":"2007","journal-title":"J Neuroimmunol"},{"key":"R22-11-20210208","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1073\/pnas.80.12.3734","article-title":"Permanent cell line expressing human factor VIII-related antigen established by hybridization.","volume":"80","author":"Edgell","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-11-20210208","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1012259529167","article-title":"Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research.","volume":"4","author":"Bouis","year":"2001","journal-title":"Angiogenesis"},{"key":"R24-11-20210208","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/0024-3205(95)00227-W","article-title":"A permanent human cell line (EA.hy926) preserves the characteristics of endothelin converting enzyme from primary human umbilical vein endothelial cells.","volume":"56","author":"Ahn","year":"1995","journal-title":"Life Sci"},{"key":"R25-11-20210208","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1471-4159.2006.03828.x","article-title":"Activation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neurons.","volume":"97","author":"Ge","year":"2006","journal-title":"J Neurochem"},{"key":"R26-11-20210208","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.phrs.2006.11.007","article-title":"Baicalin attenuates oxygen-glucose deprivation-induced injury via inhibiting NMDA receptor-mediated 5-lipoxygenase activation in rat cortical neurons.","volume":"55","author":"Ge","year":"2007","journal-title":"Pharmacol Res"},{"key":"R27-11-20210208","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jbbm.2005.10.003","article-title":"Fluorescence probes used for detection of reactive oxygen species.","volume":"65","author":"Gomes","year":"2005","journal-title":"J Biochem Biophys Methods"},{"key":"R28-11-20210208","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaci.2005.03.014","article-title":"Expression of functional cysteinyl leukotriene receptors by human basophils.","volume":"116","author":"Gauvreau","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R29-11-20210208","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.gene.2007.03.022","article-title":"Anoxia or oxygen and glucose deprivation in SH-SY5Y cells: a step closer to the unraveling of neuroglobin and cytoglobin functions.","volume":"398","author":"Fordel","year":"2007","journal-title":"Gene"},{"key":"R30-11-20210208","first-page":"1241","article-title":"Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats.","volume":"24","author":"Zhang","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"R31-11-20210208","first-page":"117","article-title":"Effects of cysteinyl receptor agonist and antagonists on rat primary cortical neurons.","volume":"36","author":"Hu","year":"2007","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"R32-11-20210208","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1152\/jappl.1991.71.4.1185","article-title":"Oxygen radical mechanisms of brain injury following ischemia and reperfusion.","volume":"71","author":"Traystman","year":"1991","journal-title":"J Appl Physiol"},{"key":"R33-11-20210208","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.brainres.2004.09.055","article-title":"Neuroprotective effects of the free radical scavenger edaravone (MCI-186) in mice permanent focal brain ischemia.","volume":"1029","author":"Shichinohe","year":"2004","journal-title":"Brain Res"},{"key":"R34-11-20210208","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.molimm.2007.05.020","article-title":"Edaravone inhibits collagen-induced arthritis possibly through suppression of nuclear factor-kappa B.","volume":"45","author":"Arii","year":"2008","journal-title":"Mol Immunol"},{"key":"R35-11-20210208","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.canlet.2005.06.039","article-title":"The radical scavenger edaravone enhances the anti-tumor effects of CPT-11 in murine colon cancer by increasing apoptosis via inhibition of NF-kappaB.","volume":"229","author":"Kokura","year":"2005","journal-title":"Cancer Lett"},{"key":"R36-11-20210208","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2222.2003.01656.x","article-title":"Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics.","volume":"33","author":"Tomari","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"R37-11-20210208","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000083325","article-title":"Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism.","volume":"136","author":"Fukushima","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"R38-11-20210208","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0021-5198(19)32413-8","article-title":"In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues.","volume":"60","author":"Obata","year":"1992","journal-title":"Jpn J Pharmacol"},{"key":"R39-11-20210208","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/mol.56.3.657","article-title":"Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.","volume":"56","author":"Sarau","year":"1999","journal-title":"Mol Pharmacol"},{"key":"R40-11-20210208","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/(SICI)1096-9888(1998110)33:11<1071::AID-JMS719>3.0.CO;2-B","article-title":"Determination of pranlukast and its metabolites in human plasma by LC\/MS\/MS with PROSPEKT on-line solid-phase extraction.","volume":"33","author":"Marchese","year":"1998","journal-title":"J Mass Spectrom"},{"key":"R41-11-20210208","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2125.1997.00650.x","article-title":"Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteers.","volume":"44","author":"Brocks","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"R42-11-20210208","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2332\/allergolint.O-08-533","article-title":"A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.","volume":"57","author":"Okubo","year":"2008","journal-title":"Allergol Int"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005344-200901000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:33:30Z","timestamp":1786037610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200901000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e318196736c","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}